APA (7th ed.) Citation

Sedding, D., Kanse, S., Preissner, K., Daniel, J., Muhl, L., Hersemeyer, K., . . . Tillmanns, H. (2006). Factor VII activating protease (FSAP) inhibits neointima formation and the G511E polymorphism is associated with atherosclerosis due to a loss of this activity. Vascular Pharmacology, 45(3), e97. https://doi.org/10.1016/j.vph.2006.08.272

Chicago Style (17th ed.) Citation

Sedding, D., et al. "Factor VII Activating Protease (FSAP) Inhibits Neointima Formation and the G511E Polymorphism Is Associated with Atherosclerosis Due to a Loss of This Activity." Vascular Pharmacology 45, no. 3 (2006): e97. https://doi.org/10.1016/j.vph.2006.08.272.

MLA (9th ed.) Citation

Sedding, D., et al. "Factor VII Activating Protease (FSAP) Inhibits Neointima Formation and the G511E Polymorphism Is Associated with Atherosclerosis Due to a Loss of This Activity." Vascular Pharmacology, vol. 45, no. 3, 2006, p. e97, https://doi.org/10.1016/j.vph.2006.08.272.